The largest database of trusted experimental protocols

Xevo tqd

Manufactured by Waters Corporation
Sourced in United States, United Kingdom, France

The Xevo TQD is a triple quadrupole mass spectrometer designed for high-performance liquid chromatography (HPLC) and ultra-performance liquid chromatography (UPLC) applications. It is capable of performing quantitative and qualitative analysis of a wide range of analytes in complex matrices.

Automatically generated - may contain errors

77 protocols using xevo tqd

1

Chiral HPLC-MS/MS for Enantioselective Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were analysed in triplicate using enantioselective high performance liquid chromatography coupled with tandem mass spectrometry system. Separation of all chiral analytes was undertaken with a CHIRALPAK ® CBH HPLC column 5 mm particle size, L  I.D. 10 cm  2.0 mm with a chiral-CBH guard column 10  2.0 mm, 5 mm particle size (Chiral Technologies, France) using a Waters ACQUITY UPLC ® system (Waters, Manchester, UK) under isocratic conditions at a 0.1 mL min À1 . The mobile phase was a solution 1 mM ammonium acetate/methanol 85:15 v/v. The temperature was kept at 4 C in the ACQUITY UPLC™ autosampler, whilst at 25 C in the column compartment. The injection volume was set at 20 mL.
A triple quadrupole mass spectrometer (Xevo TQD, Waters, Manchester, UK) equipped with an electrospray ionisation source was used in positive mode operating in the multiple reaction monitoring (MRM) mode. Table S3 shows MRM transitions used for selected analytes. MassLynx 4.1 (Waters, UK) was used to control the Waters ACQUITY system and the Xevo TQD. Data processing was carried out using TargetLynx software (Waters, Manchester, UK). Method validation data are provided in Tables S4-S8.
+ Open protocol
+ Expand
2

Metabolic Stability Assay with Microsomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human and murine pooled microsomes employed were purchased from Tebu-Xenotech (Barcelona, Spain). The compound was incubated at 37 °C with the microsomes in a 50 mM phosphate buffer (pH = 7.4) containing 3 mM MgCl2, 1 mM NADP, 10 mM glucose-6-phosphate and 1 U/mL glucose-6-phosphate-dehydrogenase. Samples (75 µL) were taken from each well at 0, 10, 20, 40 and 60 min and transferred to a plate containing 4 °C 75 µL acetonitrile and 30 µL of 0.5% formic acid in water were added for improving the chromatographic conditions. The plate was centrifuged (46000 g, 30 min) and supernatants were taken and analyzed in a UPLC-MS/MS (Xevo-TQD, Waters) by employing a BEH C18 column and an isocratic gradient of 0.1% formic acid in water: 0.1% formic acid acetonitrile (60:40). The metabolic stability of the compounds was calculated from the logarithm of the remaining compounds at each of the time points studied [19 (link)].
+ Open protocol
+ Expand
3

Metabolic Profiling of TCA Cycle Intermediates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Exploration of TCA cycle metabolites in addition to La, Pyr and ketone bodies was performed using liquid chromatography—mass spectrometry (LC-MS/MS) in all controls and in 39 subjects with muscle complaints. Analyses were performed on an Acquity UPLC system (Waters Corporation, Milford, MA, USA) coupled to a mass spectrometer XEVO TQD (Waters Corporation). The chromatographic separation was achieved on an Acquity Premier CSH Phenyl-Hexyl column (2.1 × 100 mm, 1.7 μm, Waters Corporation). Mobile phase A consisted of 0.1% formic acid in water, while mobile phase B consisted of 0.1% formic acid in acetonitrile. The column flow rate was set at 400 µL/min and the column temperature was maintained at 50 °C with an injection of 10 µL and a total run analysis of 11 min for simultaneous determination of La, Pyr, BOHB, citrate, malate, succinate, fumarate and alpha-ketoglutarate.
+ Open protocol
+ Expand
4

UPLC-ESI-MS/MS Analysis of Ethanolic Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
ET fractions
were subjected to UPLC-ESI-MS/MS analysis using negative and positive
ion acquisition modes on a triple quadruple instrument (XEVO TQD,
Waters Corporation, Milford, MA) mass spectrometer; column: ACQUITY
UPLC-BEH C18 1.7 μm × 2.1 mm × 50 mm column. The samples
were injected automatically using a Waters ACQUITY FTN autosampler.
The mobile phase was filtered using a 0.2 μm filter membrane
disc and degassed by sonication before injection. Its flow rate was
0.2 mL/min using a gradient mobile phase (methanol and water acidified
with 0.1% formic acid that applied from 10% to 30% in 5 min, then
from 30% to 70% in 10 min, then from 70% to 90% in 5 min, then holds
the gradient for 3 min, then from 90% to 10% in 3 min). The instrument
was controlled by Masslynx 4.1 software.
+ Open protocol
+ Expand
5

Pharmacokinetics of Intravenous Vinorelbine

Check if the same lab product or an alternative is used in the 5 most similar protocols
MVino plasma concentrations were monitored in a longitudinal manner. Blood samples for pharmacokinetic (PK) evaluation were collected for their trough (T0) and peak (Cmax; T2H) serum concentration levels on day 15 of cycle 1, and day 1 of cycles 2 and 3. The samples were next centrifuged and the plasma stored at −80°C until analysis. Plasma concentration of vinorelbine were quantified after simple precipitation using a fully validated liquid chromatography-tandem mass spectroscopy method (Xevo TQD, Waters, France) with a limit of quantitation of 0.1 ng/ml and a 15% precision. Because no pop-PK models was available with plasma MVino, it was not possible to derive individual parameters from the PK samples.
+ Open protocol
+ Expand
6

Neobase 2 Newborn Screening C26:0-LPC Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The analysis of C26:0-LPC is performed using the Neobase 2 newborn screening kit (PerkinElmer) following the manufacturer’s instructions. Single 3.2 mm discs are punched from DBS and transferred into 96-well plates. 125 μL of the PerkinElmer Neobase 2 extraction working solution (EWS) is added to each well. The microplate is covered with an adhesive microplate cover and shaken for 30 min with 650–750 rpm at 45°C. The microplate cover is removed and 100 μL is transferred to a new microplate and covered with an adhesive microplate cover before being analyzed with a Waters Xevo TQD.
+ Open protocol
+ Expand
7

Quantification of Intracellular Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
DMS273 cells were seeded at 4 × 105 cells per tube in 100 μM MG and the inhibitor (0 or 10 μM) in DPBS (pH 7.4) (n = 4). After 2 h incubation at 37 °C, sample was centrifuged, and supernatant was collected. Extracellular d-lactate was measured by analysis of the supernatant with Q-dsAMC. After collection of supernatants, the cells were washed with DPBS (pH 7.4) and lysed by vortexing with MeOH/H2O (80/20, v/v). The lysate was centrifuged, and the supernatant was collected. Intracellular S-D-lactoylglutathione (SLG) was measured by analysis of the cell extract with LC-MS/MS. For detection of intracellular GSH, the cell extract (15 μL) was mixed with 15 μL 5 mM Dansyl-Cl in MeCN and 15 μL 100 mM borate buffer (pH 9.1) at r.t. for 30 min, then quenched by adding 15 μL MeCN containing 10% formic acid. The mixture was subjected to LC-MS/MS. LC-MS/MS analysis was performed on an Acquity UPLC H-Class system (Waters) equipped with an Acquity UPLC BEH C18 1.7 μm (2.1 × 50 mm) column (Waters) and an MS detector (Xevo TQD, Waters). Detection was performed in the positive mode. For SLG, the fragment of m/z = 366.2 > 170.1 was used (cone voltage: 25 V, collision voltage: 25 V). For GSH, the fragment m/z = 367.2 > 170.1 was used (cone voltage: 25 V, collision voltage: 25 V).
+ Open protocol
+ Expand
8

Tear Strip Metabolite Profiling by UPLC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The DIMS analysis for the evaluation of metabolite profile in tear strip samples was performed using an Ultra Performance Liquid Chromatography Tandem Quadrupole Mass Spectrometry (UPLC/MS/MS) system (Acquity UPLC I-Class coupled to a Xevo TQD, Waters Corp., Manchester, UK). Mass spectra were acquired in positive electrospray ionization, using multiple reaction monitoring (MRM) as acquisition mode. Data are processed by using MassLynx V4.1 and NeoLynx Software (Waters Corp.). 10 μL were injected into the ion source and the run time was 1.1 minutes, injection-to-injection. The specific mass spectrometer setting conditions are reported in our previous works [37 (link),38 (link)]. A detailed list of analyzed metabolites, their ionization source settings, and their abbreviations as used in the text are available in Supplementary Table S5. The mass spectrometer ionization source settings were optimized for maximum ion yields for each analyte.
+ Open protocol
+ Expand
9

Comprehensive Analytical Techniques for Chemical Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
NMR spectra were recorded using a JEOL JNM-ECZ400 spectrometer at 400 MHz for 1H NMR and 100 MHz for 13C NMR. Mass spectra (MS) were obtained using JEOL JMS-T100LP AccuTOF LC-plus 4 G (ESI).
Preparative HPLC was performed on an Inertsil ODS-3 (10.0 × 250 mm) column (GL Sciences Inc.) using an HPLC system composed of a pump (PU-2080, JASCO) and a detector (MD-2015). Preparative MPLC was performed on an Isolera One purification system (Biotage) equipped with a Biotage SNAP Ultra C18 column (for reverse phase separation) or on an MPLC system comprising a pump and detector (EPCLC AI-580S, Yamazen) and equipped with a silica gel column (silica gel 40 μm or Amino 40 μm, Yamazen) (for normal phase separation). LC-MS analysis was performed on an Acquity UPLC H-Class system (Waters) equipped with an Acquity UPLC BEH C18 1.7 μm (2.1 × 50 mm) column (Waters) and an MS detector (QDa or Xevo TQD, Waters).
+ Open protocol
+ Expand
10

Metabolic Stability Evaluation of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human, rat, and mice microsomes employed were purchased from Tebu-Xenotech. The compound was incubated at 37 °C with the microsomes in a 50 mM phosphate buffer (pH = 7.4) containing 30 mM MgCl2, 10 mM NADP, 100 mM glucose-6-phosphate and 20 U/mL glucose-6-phosphate-dehydrogenase. Samples (75 µL) were taken from each well at 0, 10, 20, 40, and 60 min and transferred to a plate containing 4 °C 75 µL acetonitrile. Then, 30 µL of 0.5% formic acid in water was added to improve the chromatographic conditions. The plate was centrifuged (46,000× g, 30 min) and supernatants were taken and analyzed in a UPLC-MS/MS (Xevo-TQD, Waters) by employing a BEH C18 column and an isocratic gradient of 0.1% formic acid in water: 0.1% formic acid acetonitrile (60:40) for 5 minutes and a flow of 0.25 mL/min. The metabolic stability of the compounds was calculated from the logarithm of remaining compounds at each time point studied.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!